Agilent Technologies, Inc. (A)
Market Cap | 32.65B |
Revenue (ttm) | 6.63B |
Net Income (ttm) | 1.17B |
Shares Out | 284.06M |
EPS (ttm) | 4.06 |
PE Ratio | 28.30 |
Forward PE | 19.76 |
Dividend | $0.99 (0.86%) |
Ex-Dividend Date | Jul 1, 2025 |
Volume | 2,692,885 |
Open | 113.36 |
Previous Close | 112.76 |
Day's Range | 112.89 - 115.29 |
52-Week Range | 96.43 - 153.84 |
Beta | 1.27 |
Analysts | Buy |
Price Target | 143.46 (+24.81%) |
Earnings Date | May 28, 2025 |
About A
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry inst... [Read more]
Financial Performance
In 2024, Agilent Technologies's revenue was $6.51 billion, a decrease of -4.73% compared to the previous year's $6.83 billion. Earnings were $1.29 billion, an increase of 3.95%.
Financial StatementsAnalyst Forecast
According to 14 analysts, the average rating for A stock is "Buy." The 12-month stock price forecast is $143.46, which is an increase of 24.81% from the latest price.
News

Agilent Technologies, Inc. (A) Jefferies Global Healthcare Conference - (Transcript)
Agilent Technologies, Inc. (NYSE:A) Jefferies Global Healthcare Conference Call June 4, 2025 10:30 AM ET Company Participants Padraig McDonnell - CEO, President & Director Robert W. McMahon - Senior ...

Agilent Technologies, Inc. (A) Q2 2025 Earnings Conference Call Transcript
Agilent Technologies, Inc. (NYSE:A) Q2 2025 - Earnings Conference Call May 28, 2025 4:30 PM ET Company Participants Parmeet Ahuja – VP, IR Padraig McDonnell - President and CEO Robert W. McMahon - SV...

Life sciences firm Agilent beats quarterly estimates on instrument demand
Agilent Technologies beat Wall Street estimates for second-quarter profit and revenue on Wednesday, helped by strong demand for its tools and equipment used in drug development, sending its shares up ...

Agilent Reports Second-Quarter Fiscal Year 2025 Financial Results
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.67 billion for the second quarter ended April 30, 2025, representing growth of 6.0% reported and ...

Agilent Names August Specht as Chief Technology Officer
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced August Specht, Ph.D., has been named the company's Chief Technology Officer. Specht, previously vice president...

Agilent Announces the Enhanced 8850 Gas Chromatograph: Compact, Powerful, and Now Mass Spec-Connected for Superior Analytical Performance
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the latest enhancements to the Agilent 8850 Gas Chromatograph (GC), including compatibility with single and tr...

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of its latest innovation in liquid chromatography (LC)-mass detection: the Agilent InfinityLab Pro ...

Agilent Announces Cash Dividend of 24.8 Cents per Share
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies, Inc. (NYSE: A) today announced a quarterly dividend of 24.8 cents per share of common stock. The quarterly dividend will be paid on July 23,...

Pascal Soriot and Judy Gawlik Brown Named to Agilent Board of Directors
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Pascal Soriot, CEO of AstraZeneca, and Judy Gawlik Brown, founder and CEO of Downtown Advisory, have been...

Agilent Announces My Green Lab Ecolabel 2.0 for the New Infinity III LC Series
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the Infinity III LC Series — the company's latest liquid chromatography (LC) instruments — are the first ...

Agilent to Participate in Jefferies Global Healthcare Conference
SANTA CLARA, Calif--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell — along with CFO Bob McMahon — will participate in a fireside chat at the Jefferies ...

Scale Has Its Advantages: 3 A-Rated REIT Monopolies
Scale is a critical competitive advantage for companies, enabling them to expand, attract capital, and achieve strong market positions, as seen with Realty Income, Prologis, and Public Storage. Realty...

Agilent Unveils Transformative Seahorse XF Flex Analyzer: Revolutionizing 3D Tissue and Organoid Research
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced release of the new Seahorse XF Flex Analyzer, a high-performance, 24-well system designed to expand real-time ...

City Office REIT (RED PFD SER A): A High Yield, Deep Value Opportunity Worth Latching Onto
City Office REIT's Series A Preferred Shares offer a tempting yield despite recent accounting losses and systemic pressures, suggesting a potential buying opportunity. The shares are cumulative, redee...

Smackover Lithium's South West Arkansas Project Receives Unanimous Vote of Approval to Establish the Phase I Brine Production Unit from the Arkansas Oil and Gas Commission
LEWISVILLE, Ark., April 24, 2025 (GLOBE NEWSWIRE) -- Smackover Lithium, a Joint Venture (“JV”) between Standard Lithium Ltd.

Agilent Showcases Solutions and Partnerships Transforming Cancer Research and Therapeutics at AACR 2025
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced today its participation at the American Association for Cancer Research (AACR) Annual Meeting on April 25-30, 2025 i...

Agilent Receives European IVDR Certification for Companion Diagnostic Assay in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 22C3 pharmDx (Code SK006) assay has received European IVDR certification for the use as a Compan...

Fear Creates Fortunes: Grab These 7 Blue-Chip Bargains Today
Fear at extremes: Investor and consumer sentiment is near historic lows, signaling a high-probability buying opportunity, historically followed by strong 12-month gains. Economic reality check: Real-t...

Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) is pleased to announce its role in supporting Autolus Therapeutics' FDA approval for AUCATZYL®, a recently approved CAR T ther...

CORRECTING and REPLACING Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025
SANTA CLARA, Calif.--(BUSINESS WIRE)--Please replace the release with the following corrected version due to multiple revisions to the fifth paragraph. The updated release reads: AGILENT TO SHOWCASE N...

Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) is excited to announce its participation at the upcoming United States and Canadian Academy of Pathology (USCAP) Conference, w...

Agilent Research Catalyst Award Presented to Columbia University for Professor Pawel Muranski
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Columbia University has received an Agilent Research Catalyst (ARC) Award on behalf of Dr. Pawel Muranski...

Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 28-8 pharmDx kit has received two new companion diagnostic indications approvals under EU IVDR1,...

Agilent Technologies, Inc. (A) TD Cowen 45th Annual Healthcare Conference (Transcript)
Agilent Technologies, Inc. (NYSE:A) TD Cowen 45th Annual Healthcare Conference Call March 4, 2025 9:50 AM ET Company Participants Padraig McDonnell - Chief Executive Officer Bob McMahon - Chief Finan...

Agilent Technologies: Recent Price Weakness Makes This Stock A Buy
Agilent Technologies, a leader in life sciences and diagnostics, has a market cap of $38B and a 10-year CAGR of 13.6%. Key financial metrics: consistent revenue growth, stable gross profit margin abov...